FRM
Fox Run Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
4,885
+3,087
| +172% | +$1.25M | 0.33% | 28 |
|
|
2025
Q1 | $895K | Buy |
1,798
+985
| +121% | +$490K | 0.14% | 238 |
|
|
2024
Q4 | $423K | Sell |
813
-784
| -49% | -$408K | 0.08% | 494 |
|
|
2024
Q3 | $988K | Sell |
1,597
-604
| -27% | -$374K | 0.22% | 129 |
|
|
2024
Q2 | $1.22M | Buy |
+2,201
| New | +$1.22M | 0.23% | 123 |
|
|
2024
Q1 | – | Sell |
-1,753
| Closed | -$930K | – | 1059 |
|
|
2023
Q4 | $930K | Buy |
+1,753
| New | +$930K | 0.24% | 105 |
|
|
2022
Q2 | – | Sell |
-429
| Closed | -$253K | – | 745 |
|
|
2022
Q1 | $253K | Buy |
+429
| New | +$253K | 0.14% | 335 |
|
|
2021
Q2 | – | Sell |
-756
| Closed | -$345K | – | 445 |
|
|
2021
Q1 | $345K | Buy |
+756
| New | +$345K | 0.62% | 46 |
|
|
2020
Q1 | – | Sell |
-933
| Closed | -$303K | – | 357 |
|
|
2019
Q4 | $303K | Buy |
+933
| New | +$303K | 0.24% | 196 |
|
|
2019
Q1 | – | Sell |
-1,484
| Closed | -$332K | – | 690 |
|
|
2018
Q4 | $332K | Sell |
1,484
-1,052
| -41% | -$235K | 0.18% | 238 |
|
|
2018
Q3 | $619K | Sell |
2,536
-2,188
| -46% | -$534K | 0.27% | 105 |
|
|
2018
Q2 | $979K | Buy |
4,724
+1,468
| +45% | +$304K | 0.31% | 34 |
|
|
2018
Q1 | $672K | Buy |
+3,256
| New | +$672K | 0.16% | 210 |
|
|
2017
Q3 | – | Sell |
-2,800
| Closed | -$489K | – | 862 |
|
|
2017
Q2 | $489K | Sell |
2,800
-1,100
| -28% | -$192K | 0.17% | 228 |
|
|
2017
Q1 | $599K | Buy |
+3,900
| New | +$599K | 0.24% | 132 |
|